Pharmafile Logo
Pharmafocus logo
Advanced Search

oncology

Showing 15 posts of 322 posts found.

Woodley Equipment Exhibiting at Clinical Operations in Oncology Trials Europe

November 24, 2016
clinical research, clinicaltrials, oncology

Woodley Equipment is exhibiting at Clinical Operations in Oncology Trials Europe, which is taking place on 29th and 30th November Steigenberger …

News
Press release
cmglee_cambridge_cancer_research_web

Cancer Research UK enters new oncology partnership

November 7, 2016
Sales and Marketing Cancer Research UK, TYG Oncology, oncology

Cancer Research UK (CRUK) and its commercial arm, Cancer Research Technology (CRT), haven entered into an agreement with TYG Oncology …

News

Promising new study for children’s brain cancer

November 1, 2016
Manufacturing and Production brain cancer, children, oncology

There has been positive news coming from researchers at the Huntsman Cancer Institute, at the University of Utah, reporting on …

News
fdaoutsideweb

FDA grants $23 million to boost research on rare diseases

October 19, 2016
Research and Development Cancer, FDA, clinical trials, oncology

The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, …

News
c_agsandrew_-_fotolia

IBM and Quest forge precision cancer treatment partnership

October 18, 2016
Manufacturing and Production, Medical Communications Cancer, Precision Medicine, Quest, ibm, oncology

IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …

News
oncology_no_border

Pharmafocus: Advances in Oncology available now!

September 30, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, oncology, pharmafocus supplement

The latest issue of Pharmafocus is now available, and with it comes Advances in Oncology, our supplement featuring all the …

News
t_cell_grey_killing_tumour_cell_yellow

Foundation Medicine adds new immunotherapy features to its gene profiling products

August 23, 2016
Manufacturing and Production, Research and Development FoundationOne, oncology, tumour

Foundation Medicine hopes to enhance oncologist insight into potential immunotherapy responses with the addition of new clinical markers to its …

News

Pfizer acquires Medivation for $14 billion

August 22, 2016
Sales and Marketing Medivation, Pfizer, acquisition, oncology

Pfizer has sealed the deal to acquire US cancer drug company Medivation for close to $14 billion in a move …

News
shutterstock_141299494

GSK, Roche and Novo back $86 million immuno-oncology startup

August 17, 2016
Research and Development CD47, Cancer, GSK, Novo, Roche, Tioma, oncology

Brisbane-based venture-stage biopharmaceutical company Tioma Therapeutics has announced it has raised $86 million in Series A venture financing for its …

News
adaptimmune_lab_scientists_growing_research_cells_jpg-web

Bad news for Adaptimmune as partial clinical hold placed on T-cell oncology trial

August 4, 2016
Research and Development Adaptimmune, T cell, oncology, t-cell

Adaptimmune Therapeutics has received notice from the US Food and Drug Administration (FDA) that a partial clinical hold has been …

News
celgene_1_02

Celgene says its Revlimid gets European approval to treat rare non-Hodgkin’s lymphoma

July 15, 2016
Medical Communications, Research and Development, Sales and Marketing Celgene, European Commission, Revlimid, drug approval, drug trial, oncology

Celgene (Nasdaq: CELG) said the European Commission (EC) has approved Revlimid (lenalidomide) to treat a rare form of non-Hodgkin’s lymphoma. 

News
lab

Federal panel to review proposal for first human CRISPR test

June 20, 2016
Research and Development, Sales and Marketing crispr, gene editing, human testing, oncology

A US Federal safety board is set to review a proposal for the first human use of the gene editing …

News

Nice backs BMS’ combination immunotherapy Opdivo, Yervoy to treat skin cancer

June 17, 2016
Medical Communications, Research and Development, Sales and Marketing BMS, NICE, oncology, opdivo, regulation, skin cancer

The National Institute for Health and Care Excellence (Nice) has backed a combination of Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) and …

News
ascologo

Drug Pricing: Cancer drugs cost the most in US, but most unaffordable in India, China – Study

June 7, 2016
Medical Communications, Research and Development, Sales and Marketing ASCO, Drug pricing, oncology, social

Cancer drugs are less affordable in low-income countries, despite the lower retail prices, according to a study released at the …

Feature
cancer_cells

Global oncology market to reach $150 billion by 2020, says IMS Health

June 2, 2016
Research and Development IMS Health, annual global growth, cancer drugs, oncology

Global sales of oncology drugs rose to $107 billion in 2015, according to a new IMS Health report, with growth …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025